Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Swift Biosciences Partners with MGI for High Throughput Genomic Sequencing


ANN ARBOR, Mich., Jan. 14, 2020 /PRNewswire/ -- Swift Biosciences, Inc. ("Swift"), a leader in design and manufacturing of unique DNA and RNA library preparation and normalization kits for Next-Generation Sequencing (NGS), and MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, today announced a co-marketing agreement for Swift's DNA and RNA library preparation products in Europe and Asia Pacific markets.

Swift Biosciences develops enabling technologies for genomics, translational, and clinical research. For more information, visit SwiftBioSci.com and follow Twitter (@SwiftBioSci).

With this agreement, Swift and MGI will work to enable Swift's library preparation kits on MGI's DNBSEQtm sequencers. Swift's 2S Turbo DNA for whole genome and targeted sequencing as well as Rapid RNA and Methyl-Seq DNA Library Kits, powered by its patented Adaptase® technology, are among the first product lines selected. This partnership will provide sequencing users with the opportunity to leverage Swift's expertise in library generation technologies on MGI's fast growing install base. 

Since its launch in 2018, Swift's 2S Turbo has been adopted into several large-scale production laboratories, providing a fast, consistent and cost-effective solution for high-throughput sequencing. Swift's newly released Rapid RNA Library Kits enable constructing stranded RNA-Seq libraries in less time than competing offerings on the market with robust mapping. The Accel-NGS Methyl-Seq DNA Library Kit has become the market proven gold standard of methylation profiling. 

The synergy between these two leading genomic companies will assist a larger number of laboratory and research facilities in the APAC and EMEA markets to achieve highly reproducible results at lower cost of reagents and sequencing.

"MGI is a valued partner and we will continue to grow the relationship.  We have several exciting products launching this year and our R&D and Manufacturing groups will be looking to enable the technology on the MGI platform as we continue our strategic worldwide growth," said Nathan Wood, President and CEO of Swift Biosciences.

"We are excited to work with Swift Biosciences in this partnership," said Jiang Hui, MGI Chief Operating Officer. "MGI is demonstrating its commitment to continue opening its platform and bring more applications to our sequencing and grow our application community in order to support our customers."

About MGI

MGI, a subsidiary of BGI Group, is committed to building core tools and technology to lead life science through intelligent innovation.  Learn more at https://en.mgitech.cn/

About Swift Biosciences

Swift Biosciences develops enabling technologies for genomics, translational, and clinical research. For more information, visit SwiftBioSci.com and follow Twitter (@SwiftBioSci).

CONTACT: Camille Cappello, [email protected] 

SOURCE Swift Biosciences, Inc.


These press releases may also interest you

at 09:15
101 Mobility® is thrilled to announce the opening of its newest location in Eden Prairie, marking the introduction of the city's first nationally branded full-service provider of a wide range of mobility equipment. This includes stair lifts, ramps,...

at 09:15
Vibrant Wellness, a leader in specialized diagnostics and personalized health tools, announced today that its Tickborne Testing received approval from The Wadsworth Center, part of the New York State Department of Health.This approval enables Vibrant...

at 09:07
Olympus announced today that it has been awarded a contract for its advanced energy portfolio by Provista Inc. This new, nationwide agreement provides Provista members with negotiated pricing for Olympus® energy products, including the...

at 09:05
Adolescence isn't just a phase; it's a time of unparalleled growth and an opportunity for developing strengths that will influence our adult lives. Recognizing the potential of this developmental stage, Committee for Children a global nonprofit and...

at 09:00
The Prelude Network® (Prelude), the largest network of fertility clinics in North America, announced today an expansion of its partnership with Labcorp , a global leader of innovative diagnostic and biopharma laboratory services, to serve as its...

at 09:00
LISCure Biosciences, a leading clinical-stage biopharmaceutical company focused on discovering and developing innovative microbiome-based therapies,...



News published on and distributed by: